Integrated Multi-Modality Transfusion-Transmitted Disease (TTD) Testing Systems for Armed Services Blood Bank Center-Europe (ASBBC-EUR), Landstuhl Regional Medical Center (LRMC), Germany
Contract Opportunity Analysis
The Defense Health Agency is conducting market research to identify capable sources that can provide a complete, integrated multi-modality Transfusion-Transmitted Disease testing solution for the Armed Services Blood Bank Center-Europe at Landstuhl Regional Medical Center in Germany. The required scope includes the supply, installation, validation, training, ongoing maintenance, and reagent support for three complementary testing platforms capable of performing the full suite of FDA-required blood-donor screening assays. Systems must be FDA Center for Biologics Evaluation and Research cleared or licensed, operate directly on German power sources, and fit within a constrained 585-square-foot basement laboratory. Capability statements must be submitted via email to Cliff Roberts and Matthew Elden, with the final solution targeting a operational date no later than September 27, 2027.